Researchers developed light-responsive azobenzene polymer sensors that conform to neuronal structures, enhancing monitoring ...
In a recent article, researchers introduced light-responsive azobenzene polymer thin films as advanced neuronal interfaces, ...
Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...
NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system ...
Researchers link microscopic protein structures and cellular interactions to individual differences in brain connectivity, ...
Decision making is the process of choosing among alternatives associated with different outcomes. Deciding among multiple options can take the form of selecting a course of action or judging among ...
The chapter concludes with an assessment of several approaches to religion grounded in biology and neuroscience. Get access to the full version of this content by using one of the access options below ...
Bristol Neuroscience will be hosting a number of high-profile speakers for the 2024-25 academic year.
She is an early-career leader with the Biodiversity Council. “Nature positive” is seemingly everywhere. Two weeks ago, Australia hosted the first Global Nature Positive Summit. This week ...
Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study.
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Alto Neuroscience, Inc. (ANRO – Research Report), with a price target of $32.00. The company’s shares ...